c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence

被引：0
|
作者：
Jaudah Al-Maghrabi
Eman Emam
Wafaey Gomaa
Moaath Saggaf
Abdelbaset Buhmeida
Mohammad Al-Qahtani
Mahmoud Al-Ahwal
机构：
[1] King Abdulaziz University,Scientific Chair for Colorectal Cancer
[2] King Abdulaziz University,Department of Pathology, Faculty of Medicine
[3] King Abdulaziz University,Center of Excellence in Genomic Medicine Research
[4] Alexandria University,Department of Pathology, Faculty of Medicine
[5] Minia University,Department of Pathology, Faculty of Medicine
[6] King Abdulaziz University,Department of Medicine, Faculty of Medicine
来源：
BMC Cancer | / 15卷
关键词：
Colorectal carcinoma; c-met proto-oncogene; Clinicopathological characteristics; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence
    Al-Maghrabi, Jaudah
    Emam, Eman
    Gomaa, Wafaey
    Saggaf, Moaath
    Buhmeida, Abdelbaset
    Al-Qahtani, Mohammad
    Al-Ahwal, Mahmoud
    BMC CANCER, 2015, 15
  • [2] Prognostic value of c-Met in colorectal cancer:A metaanalysis
    Yan Liu
    Xiao-Feng Yu
    Jian Zou
    Zi-Hua Luo
    World Journal of Gastroenterology, 2015, (12) : 3706 - 3710
  • [3] c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases
    Zeng, Zhao-Shi
    Weiser, Martin R.
    Kuntz, Eleanor
    Chen, Chin-Tung
    Khan, Sajid A.
    Forslund, Ann
    Nash, Garrett M.
    Gimbel, Mark
    Yamaguchi, Yuka
    Culliford, Alfred T.
    D'Alessio, Matthew
    Barany, Francis
    Paty, Philip B.
    CANCER LETTERS, 2008, 265 (02) : 258 - 269
  • [4] The coordinated functional expression of epidermal growth factor receptor and c-met in colorectal carcinoma metastasis
    Herynk, MH
    Radinsky, R
    IN VIVO, 2000, 14 (05): : 587 - 596
  • [5] Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma
    Asaoka, Yoshinari
    Tateishi, Ryosuke
    Hayashi, Akimasa
    Ushiku, Tetsuo
    Shibahara, Junji
    Kinoshita, Jun
    Ouchi, Yoshiumi
    Koike, Masamichi
    Fukayama, Masashi
    Shiina, Shuichiro
    Koike, Kazuhiko
    ONCOLOGY, 2020, 98 (03) : 186 - 194
  • [6] c-Met: A potential therapeutic target for hepatocellular carcinoma
    Gao, Jianjun
    Inagaki, Yoshinori
    Xue, Xia
    Qu, Xianjun
    Tang, Wei
    DRUG DISCOVERIES AND THERAPEUTICS, 2011, 5 (01) : 2 - 11
  • [7] Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated β-catenin
    Matthew H. Herynk
    Rachael Tsan
    Robert Radinsky
    Gary E. Gallick
    Clinical & Experimental Metastasis, 2003, 20 : 291 - 300
  • [8] Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated β-catenin
    Herynk, MH
    Tsan, R
    Radinsky, R
    Gallick, GE
    CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (04) : 291 - 300
  • [9] Diagnosis and management of local and locoregional recurrence of colorectal carcinoma (Local and Locoregional Recurrence of Colon Carcinoma)
    Prochotsky, A.
    Okolicany, R.
    Sekac, J.
    Skultety, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (09): : 569 - 573
  • [10] Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer
    Zhaoshi Zeng
    Martin R Weiser
    Matt D’Alessio
    Andrew Grace
    Jinru Shia
    Philip B. Paty
    Clinical & Experimental Metastasis, 2004, 21 : 409 - 417
12345